Literature DB >> 26656889

Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers.

Gregory H Taylor1, Adrienne A Williams2, Alfredo Garzino-Demo3.   

Abstract

Increased levels of the proinflammatory cytokine IL-8 are detected in the sputum of patients with chronic obstructive pulmonary disease (COPD) and during the pathological pulmonary manifestations of HIV infection : To explore a potential interrelationship between smoking, highly active antiretroviral therapy (HAART) and HIV immune status, we collected sputum samples, along with complete pulmonary function tests from groups of HIV-infected women smokers who were either on or off HAART. Analysis of the patient's sputum for cell count along with quantitative measures of IL-8 was performed and correlated with concurrent assessment of pulmonary function test (PFT). We found that HIV-positive smokers had decreased measurements on PFT of the diffusing capacity of the lung for carbon monoxide (D(LCO)) compared to standard reference values that did not differ with HAART usage. HAART, when controlled for CD4, showed a suppressive effect on the levels of pro inflammatory cytokine IL-8 in sputum. We conclude that in the era of HAART, HIV along with concurrent tobacco smoking is associated with declines in PFT in HIV-infected women. The use of HAART in patients appears to mitigate the increases in IL-8 levels in relation to immune status based on CD4 count. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; IL-8; antiretroviral therapy; pulmonary function; smoking; tobacco

Mesh:

Substances:

Year:  2015        PMID: 26656889      PMCID: PMC4857151          DOI: 10.1093/femspd/ftv115

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  57 in total

1.  Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction.

Authors:  Helena Forsslund; Mikael Mikko; Reza Karimi; Johan Grunewald; Åsa M Wheelock; Jan Wahlström; C Magnus Sköld
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

2.  Changes in lung lymphocyte populations reflect those seen in peripheral blood in HIV-1 positive individuals.

Authors:  M Bofill; M Lipman; J E McLaughlin; M A Johnson; L W Poulter
Journal:  Eur Respir J       Date:  1998-03       Impact factor: 16.671

3.  Measurement of antiretroviral drugs in the lungs of HIV-infected patients.

Authors:  Homer L Twigg; Carol T Schnizlein-Bick; Michael Weiden; Fred Valentine; Joseph Wheat; Richard B Day; Helen Rominger; Lu Zheng; Ronald G Collman; Robert W Coombs; R Pat Bucy; Naser L Rezk; Angela Dm Kashuba
Journal:  HIV Ther       Date:  2010-03-01

4.  Diurnal variations in human pulmonary function.

Authors:  Boris I Medarov; Valentin A Pavlov; Leonard Rossoff
Journal:  Int J Clin Exp Med       Date:  2008-07-12

Review 5.  The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what?

Authors:  Jørgen Vestbo; Suzanne S Hurd; Roberto Rodriguez-Roisin
Journal:  Clin Respir J       Date:  2012-10       Impact factor: 2.570

6.  Developing COPD: a 25 year follow up study of the general population.

Authors:  A Løkke; P Lange; H Scharling; P Fabricius; J Vestbo
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

7.  Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation.

Authors:  Amanda J Chase; Hung-Chih Yang; Hao Zhang; Joel N Blankson; Robert F Siliciano
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

8.  Plasma cytokine levels in Tanzanian HIV-1-infected adults and the effect of antiretroviral treatment.

Authors:  Judith M Haissman; Lasse S Vestergaard; Samuel Sembuche; Christian Erikstrup; Bruno Mmbando; Samuel Mtullu; Martha M Lemnge; Jan Gerstoft; Henrik Ullum
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12-01       Impact factor: 3.731

Review 9.  Will expanded ART use reduce the burden of HIV-associated chronic lung disease?

Authors:  Ken M Kunisaki
Journal:  Curr Opin HIV AIDS       Date:  2014-01       Impact factor: 4.283

10.  HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.

Authors:  Kyra Oswald-Richter; Stacy M Grill; Nikki Shariat; Mindy Leelawong; Mark S Sundrud; David W Haas; Derya Unutmaz
Journal:  PLoS Biol       Date:  2004-07-13       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.